Dual Metabolomic Platforms Identified a Novel Urinary Metabolite Signature for Hepatitis B Virus-Infected Patients with Depression

References

• Wu Y, Jin A, Xie G, et al. The 20 most important and most preventable health problems of China: a Delphi Consultation of Chinese Experts. Am J Public Health. 2018;108(12):1592–1598. doi:10.2105/AJPH.2018.304684
   PubMedGoogle Scholar
• Yuen MF, Chen DS, Dusheiko GM, et al. Hepatitis B virus infection. Nat Rev Dis Primers. 2018;4:18035. doi:10.1038/nrdp.2018.35
   PubMed Web of Science ®Google Scholar
• Mirabdolhagh Hazaveh M, Dormohammadi Toosi T, Nasiri Toosi M, Tavakoli A, Shahbazi F. Prevalence and severity of depression in chronic viral hepatitis in Iran. Gastroenterol Rep (Oxf). 2015;3(3):234–237. doi:10.1093/gastro/gou091
   PubMedGoogle Scholar
• Keskin G, Gümüs AB, Orgun F. Quality of life, depression, and anxiety among hepatitis B patients. Gastroenterol Nurs. 2013;36(5):346–356. doi:10.1097/SGA.0b013e3182a788cc
   PubMedGoogle Scholar
• Duan Z, Kong Y, Zhang J, Guo H. Psychological comorbidities in Chinese patients with acute-on-chronic liver failure. Gen Hosp Psychiatry. 2012;34(3):276–281. doi:10.1016/j.genhosppsych.2011.11.012
   PubMedGoogle Scholar
• Huang X, Zhang H, Qu C, Liu Y, Bian C, Xu Y. Depression and insomnia are closely associated with thyroid hormone levels in chronic hepatitis B. Med Sci Monit. 2019;25:2672–2678. doi:10.12659/MSM.914444
   PubMedGoogle Scholar
• Chen JW, Xie SQ. Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease. Neuropsychiatr Dis Treat. 2018;14:547–552. doi:10.2147/NDT.S159636
   PubMed Web of Science ®Google Scholar
• Chen JJ, Xie J, Zeng L, Zhou CJ, Zheng P, Xie P. Urinary metabolite signature in bipolar disorder patients during depressive episode. Aging (Albany NY). 2019;11(3):1008–1018. doi:10.18632/aging.101805
   PubMedGoogle Scholar
• Lai CH. Promising neuroimaging biomarkers in depression. Psychiatry Investig. 2019;16(9):662–670. doi:10.30773/pi.2019.07.25.2
   PubMed Web of Science ®Google Scholar
• Carboni L, McCarthy DJ, Delafont B, et al. Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies. Transl Psychiatry. 2019;9(1):182. doi:10.1038/s41398-019-0521-7
   PubMedGoogle Scholar
• Pan JX, Xia JJ, Deng FL, et al. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study. Transl Psychiatry. 2018;8(1):130. doi:10.1038/s41398-018-0183-x
   PubMedGoogle Scholar
• Hou LJ, Wang HW, Wei XX, et al. Urinary metabonomics for diagnosis of depression in hepatitis B virus-infected patients. Iran Red Crescent Med J. 2015;17(4):e27359. doi:10.5812/ircmj.17(4)2015.27359
   PubMedGoogle Scholar
• Hou L, Wei X, Zhuo Y, et al. GC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old age. Aging (Albany NY). 2018;10(9):2252–2265. doi:10.18632/aging.101535
   PubMedGoogle Scholar
• Williams R, Lenz EM, Wilson AJ, et al. A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats. Mol Biosyst. 2006;2(3–4):174–183. doi:10.1039/b516356k
   PubMedGoogle Scholar
• Chen J, Bai S-J, Li W, et al. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders. Transl Psychiatry. 2018;8(1):192. doi:10.1038/s41398-018-0245-0
   PubMedGoogle Scholar
• Bouatra S, Aziat F, Mandal R, et al. The human urine metabolome. PLoS One. 2013;8(9):e73076. doi:10.1371/journal.pone.0073076
   PubMed Web of Science ®Google Scholar
• Chen J, Liu Z, Fan S, et al. Combined application of NMR-and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder. Sci Rep. 2014;4:5855. doi:10.1038/srep05855
   PubMed Web of Science ®Google Scholar
• Tao R, Huang X, Wang J, Zhang H, Zhang Y, Li M. Proposed diagnostic criteria for internet addiction. Addiction. 2010;105(3):556–564. doi:10.1111/j.1360-0443.2009.02828.x
   PubMed Web of Science ®Google Scholar
• MacIntyre DA, Jimenez B, Lewintre EJ, et al. Serum metabolome analysis by 1 H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. Leukemia. 2010;24(4):788–797. doi:10.1038/leu.2009.295
   PubMed Web of Science ®Google Scholar
• Chen JJ, Xie J, Li WW, et al. Age-specific urinary metabolite signatures and functions in patients with major depressive disorder. Aging (Albany NY). 2019;11(17):6626–6637. doi:10.18632/aging.102133
   PubMedGoogle Scholar
• Ménard C, Hodes GE, Russo SJ. Pathogenesis of depression: insights from human and rodent studies. Neuroscience. 2016;321:138–162. doi:10.1016/j.neuroscience.2015.05.053
   PubMed Web of Science ®Google Scholar
• Chen JJ, Xie J, Zeng BH, et al. Absence of gut microbiota affects lipid metabolism in the prefrontal cortex of mice. Neurol Res. 2019;41(12):1104–1112. doi:10.1080/01616412.2019.1675021
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhu B, Chen Z, et al. Prevalence and predisposing factors of depressive symptoms in patients with stable coronary artery disease: a cross-sectional single-center study. Aging (Albany NY). 2019;11(12):3958–3968. doi:10.18632/aging.102026
   PubMedGoogle Scholar
• Chen JJ, He S, Fang L, et al. Age-specific differential changes on gut microbiota composition in patients with major depressive disorder. Aging (Albany NY). 2020;12(3):2764–2776. doi:10.18632/aging.102775
   PubMedGoogle Scholar
• Zheng P, Zeng B, Zhou C, et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry. 2016;21(6):786–796. doi:10.1038/mp.2016.44
   PubMed Web of Science ®Google Scholar
• Chen JJ, Zheng P, Liu YY, et al. Sex differences in gut microbiota in patients with major depressive disorder. Neuropsychiatr Dis Treat. 2018;14:647–655. doi:10.2147/NDT.S159322
   PubMed Web of Science ®Google Scholar
• Zheng P, Wang Y, Chen L, et al. Identification and validation of urinary metabolite biomarkers for major depressive disorder. Mol Cell Proteomics. 2013;12(1):207–214. doi:10.1074/mcp.M112.021816
   PubMed Web of Science ®Google Scholar
• Kang Y, Cai Y. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy. J Hosp Infect. 2017;96(4):342–348. doi:10.1016/j.jhin.2017.04.007
   PubMedGoogle Scholar
• Wang J, Wang Y, Zhang X, et al. Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patients. Front Microbiol. 2017;8:2222. doi:10.3389/fmicb.2017.02222
   PubMed Web of Science ®Google Scholar